NO331018B1 - In vitro fremgangsmate ved bestemmelse av pre-neoplastiske og/eller neoplastiske tilstander hos pattedyr ved purinergisk reseptorekspresjon, samt anvendelse og sett for slik pavisning - Google Patents

In vitro fremgangsmate ved bestemmelse av pre-neoplastiske og/eller neoplastiske tilstander hos pattedyr ved purinergisk reseptorekspresjon, samt anvendelse og sett for slik pavisning

Info

Publication number
NO331018B1
NO331018B1 NO20015157A NO20015157A NO331018B1 NO 331018 B1 NO331018 B1 NO 331018B1 NO 20015157 A NO20015157 A NO 20015157A NO 20015157 A NO20015157 A NO 20015157A NO 331018 B1 NO331018 B1 NO 331018B1
Authority
NO
Norway
Prior art keywords
neoplastic
mammals
kit
screening
determination
Prior art date
Application number
NO20015157A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015157L (no
NO20015157D0 (no
Inventor
Michael Slater
Julian Alexander Barden
Original Assignee
Biosceptre Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosceptre Int Ltd filed Critical Biosceptre Int Ltd
Publication of NO20015157D0 publication Critical patent/NO20015157D0/no
Publication of NO20015157L publication Critical patent/NO20015157L/no
Publication of NO331018B1 publication Critical patent/NO331018B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20015157A 1999-04-21 2001-10-22 In vitro fremgangsmate ved bestemmelse av pre-neoplastiske og/eller neoplastiske tilstander hos pattedyr ved purinergisk reseptorekspresjon, samt anvendelse og sett for slik pavisning NO331018B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP9911A AUPP991199A0 (en) 1999-04-21 1999-04-21 Methods for diagnosing pre-cancerous and cancerous conditions
PCT/AU2000/000363 WO2001006259A1 (en) 1999-04-21 2000-04-26 A method for identifying pre-neoplastic and/or neoplastic states in mammals

Publications (3)

Publication Number Publication Date
NO20015157D0 NO20015157D0 (no) 2001-10-22
NO20015157L NO20015157L (no) 2001-12-21
NO331018B1 true NO331018B1 (no) 2011-09-12

Family

ID=3814111

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015157A NO331018B1 (no) 1999-04-21 2001-10-22 In vitro fremgangsmate ved bestemmelse av pre-neoplastiske og/eller neoplastiske tilstander hos pattedyr ved purinergisk reseptorekspresjon, samt anvendelse og sett for slik pavisning

Country Status (15)

Country Link
US (3) US7183064B1 (de)
EP (1) EP1179183B1 (de)
JP (1) JP4633984B2 (de)
KR (1) KR100819395B1 (de)
CN (1) CN100557445C (de)
AT (1) ATE456799T1 (de)
AU (2) AUPP991199A0 (de)
CA (1) CA2371163A1 (de)
DE (1) DE60043775D1 (de)
DK (1) DK1179183T3 (de)
ES (1) ES2340137T3 (de)
HK (1) HK1044190A1 (de)
NO (1) NO331018B1 (de)
WO (1) WO2001006259A1 (de)
ZA (1) ZA200108616B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
ES2383712T3 (es) * 2001-01-17 2012-06-25 Biosceptre International Limited Diagnóstico y tratamiento de cánceres y otras afecciones
US8067550B2 (en) 2006-10-10 2011-11-29 Biosceptre International Limited Hybridomas producing antibodies against non functional P2X7 receptor
AU2013238152B2 (en) * 2007-09-14 2015-09-24 Biosceptre International Limited Purinergic (P2X) receptors in extra-cellular body fluid
AU2008299594B2 (en) 2007-09-14 2013-10-03 Biosceptre International Limited Purinergic (P2X) receptors in extra-cellular body fluid
ES2619681T3 (es) 2007-09-14 2017-06-26 Biosceptre (Aust) Pty Ltd Novedosos epítopos P2X7
KR101701300B1 (ko) 2008-07-04 2017-02-01 바이오셉터 (어스트) 피티와이 엘티디 항­ｐ２ｘ７ 펩티드 및 에피토프
US9260508B2 (en) * 2008-12-19 2016-02-16 Ablynx N.V. Method for generation of immunoglobulin sequences
JP5936067B2 (ja) 2009-08-20 2016-06-15 バイオセプター・（オーストラリア）・ピーティーワイ・リミテッド 抗ｐ２ｘ７受容体抗体およびその断片
EP3321285B1 (de) 2009-12-24 2019-04-24 Biosceptre (Aust) Pty Ltd Antikörper gegen nichtfunktionelle oligomere p2x7-rezeptoren
WO2012031333A1 (en) 2010-09-10 2012-03-15 Biosceptre International Limited Companion animal treatments
AU2012278921B2 (en) 2011-07-01 2016-11-10 Biosceptre International Limited Combination therapy
EP4001310A3 (de) * 2014-05-02 2022-08-10 MedImmune Limited Ionenkanalmodulatoren und verwendungen davon
JP7127021B2 (ja) 2016-10-21 2022-08-29 バイオセプター・（オーストラリア）・ピーティーワイ・リミテッド 細胞傷害性粒子

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE920765A1 (en) * 1991-03-12 1992-09-23 Scripps Research Inst Cell surface receptors homologous to coagulation factors v¹and viii
JP3084982B2 (ja) * 1992-11-25 2000-09-04 富士電機株式会社 半導体装置
WO1995033048A2 (en) * 1994-05-27 1995-12-07 Glaxo Group Limited P2x receptors (purinoceptor family)
CA2228999A1 (en) * 1995-08-09 1997-02-20 Institut National De La Sante Et De La Recherche Medicale Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis
WO1997041222A1 (en) 1996-04-30 1997-11-06 Smithkline Beecham P.L.C. HUMAN P2x4 RECEPTOR SPLICE-VARIANTS
US6303338B1 (en) * 1996-08-16 2001-10-16 Human Genome Sciences, Inc. Pancreas-derived plasminogen activator inhibitor
JP3885177B2 (ja) 1997-03-26 2007-02-21 大塚製薬株式会社 ヒト遺伝子
US6133434A (en) * 1997-04-28 2000-10-17 Glaxo Group Limited Purinergic receptor
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
ES2383712T3 (es) * 2001-01-17 2012-06-25 Biosceptre International Limited Diagnóstico y tratamiento de cánceres y otras afecciones

Also Published As

Publication number Publication date
DE60043775D1 (de) 2010-03-18
AU3949000A (en) 2001-02-05
AU779845B2 (en) 2005-02-17
CN100557445C (zh) 2009-11-04
US20110111431A1 (en) 2011-05-12
ATE456799T1 (de) 2010-02-15
CN1355886A (zh) 2002-06-26
EP1179183B1 (de) 2010-01-27
EP1179183A4 (de) 2003-01-22
KR100819395B1 (ko) 2008-04-04
JP4633984B2 (ja) 2011-02-16
US7183064B1 (en) 2007-02-27
ES2340137T3 (es) 2010-05-31
EP1179183A1 (de) 2002-02-13
JP2003504643A (ja) 2003-02-04
WO2001006259A1 (en) 2001-01-25
ZA200108616B (en) 2002-06-13
DK1179183T3 (da) 2010-05-25
NO20015157L (no) 2001-12-21
AUPP991199A0 (en) 1999-05-13
CA2371163A1 (en) 2001-01-25
HK1044190A1 (en) 2002-10-11
KR20020022651A (ko) 2002-03-27
NO20015157D0 (no) 2001-10-22
US20070248963A1 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
NO331018B1 (no) In vitro fremgangsmate ved bestemmelse av pre-neoplastiske og/eller neoplastiske tilstander hos pattedyr ved purinergisk reseptorekspresjon, samt anvendelse og sett for slik pavisning
BRPI9912227B8 (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
CY1111098T1 (el) Bodipy διαιθυλοακεταλη αμινοακεταλδεϋδης
AU2001268449A1 (en) Toxicity typing using liver stem cells
EP0915173A3 (de) Reagentiensatz und Verfahren für Fluoreszenzerkennungstest
ATE424560T1 (de) Marker für neuromyelitis optica
BRPI0410261A (pt) método de detecção de probnp natural
AU7709198A (en) Low background multi-well plates for fluorescence measurements of biological andbiochemical samples
DE60138415D1 (de) Expression von p2y-purinergem rezeptor zur identifizierung präneoplastischer und neoplastischer zustände
WO2001092877A3 (en) Method of identifying and/or isolating stem cells
ATE234364T1 (de) Phycobilisome, derivate und ihre verwendung
BR0110603A (pt) Couro natural revestido com poliuretano e método de preparação de couro natural revestido
RS20060255A (en) Quick test for the diagnosis of alzheimer's disease
AU1871001A (en) Assay
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
BR0215452A (pt) Teste de proteìna tirosina-fosfatase (ptpase) altamente sensitivo com o emprego de 6,8-diflúor-4-metil-umbeliferilfosfato
WO2006023211A3 (en) Antigens targeted by pathogenic ai4 t cells in type 1 diabetes and uses thereof
AU8904598A (en) Methods, kits, electrodes and compositions for assessing the level of an analyteof interest in fluid samples
EP1456645A4 (de) Verfahren zur bestimmung der prognose von krebspatienten mittels tucan
WO2001004305A3 (en) Human proteins involved in detoxification
BR7800423U (pt) Boné com suporte para óculos
WO1998015650A3 (en) Hydronephrosis gene (hng) and its use
WO2004019880A3 (en) Aw755252-interacting proteins and use thereof

Legal Events

Date Code Title Description
MK1K Patent expired